Nevertheless, this study is a promotion to understand the role of mTOR pathway in autophagy mechanism of patients with schizophrenia, and to explore whether these genes are potential biomarkers for the diagnosis of and determination of therapeutic efficacy in patients with schizophrenia. This evidence concerns the gene MTOR and schizophrenia.